The GEO Group delivered a clean earnings beat in the third quarter, but the top line tells a more nuanced story. Adjusted EPS of $0.39 topped the $0.35 consensus by 11.4% and grew 56.0% year over year. Revenue of $761.06 million rose 11.5% but missed the $777.58 million consensus by 2.1%. That is the central tension. Profitability is expanding faster than the business is growing, while revenue growth is visibly decelerating. According to the call, year-over-year revenue growth has slowed from 17% in the first quarter to 15% in the second and 12% now, as the wave of 2025 contract activations laps.

The quality of the earnings beat holds up reasonably well. Adjusted EBITDA rose 21% to a record $145.3 million, up from $142 million in the second quarter and $131.4 million in the first. Operating expenses fell to roughly 72.6% of revenue from 74.6% a year ago, a genuine margin improvement. Per-share results also had help: diluted share count dropped to 132.0 million from 140.0 million. GAAP EPS of $0.37 compares with $1.24 a year ago, but the prior-year figure was inflated by a $232 million divestiture gain. On a GAAP basis, the decline reflects that comparison rather than operating weakness. One cost line moved the wrong way. G&A climbed to about 9.5% of revenue from roughly 9% as business-development spending rose.

The operating metrics on the call were uniformly stronger.

• ICE beds under contract rose to about 33,000, up from 29,500 last quarter and 26,000 in the first quarter.
• Idle beds fell to roughly 2,900 from 4,500.
• ISAP participants reached about 190,000, and ankle monitors climbed to 58,000 from 54,000.
• The electronic monitoring segment returned to year-over-year growth of 1.6%, its first growth in several years, after declining 3.5% in the second quarter.

Management raised full-year adjusted EBITDA guidance for the third straight quarter, to $568-$573 million from $550-$560 million. That puts the cumulative increase at about 15% above the initial outlook. Full-year adjusted EPS guidance stands at $1.40-$1.44. Earnings Whispers characterizes the update as a narrowing, while the company describes its profit targets as increased. The two views reconcile this way: the profit ranges moved up, while the revenue range of $2.975-$3.025 billion and the fourth-quarter revenue guide of $777-$827 million keep the top-line outlook bounded.

The forward catalysts are substantial, and much of the revenue story belongs to 2027. New and expanded contracts include:

• Big Spring Complex: about $200 million annually, with normalized contribution expected in the second quarter of 2027.
• Big Horn: about $85 million annually.
• Rivers: about $80 million annually.
• Northwest Tacoma: a new 10-year contract worth about $140 million annually.
• Adelanto: a staffing modification adding about $60 million.

The $950 million Adelanto sale, roughly $705 million net, funded redemption of the 8.625% secured notes. That leaves $625 million of 10.25% unsecured notes, net leverage near 1x, and about $600 million of liquidity. The buyback authorization rose to $1.25 billion, and 10.1 million shares have already been retired. Bears still have legitimate ammunition:

• Ownership-cost pricing on Adelanto must be renegotiated now that GEO no longer owns the facility.
• The up to four additional facility sales lack definitive agreements.
• The ISAP contract has roughly a year left.
• Florida contracts remain deferred to July 2027.
• Unreimbursed capex guidance edged up to $140-$150 million.
• Start-up costs will weigh before the new facilities normalize.

The market setup is more complicated than the surprise implies. Investor sentiment remained positive but weakened meaningfully, falling from 0.38 to 0.16 ahead of the report. Shares hit a 52-week high of $33.17 on October 5, the day the expanded buyback was announced. They then slid to an inter-earnings low of $25.75 on November 4, the day before the report. At $27.53, the stock is down 11.8% since the open following the August report and 17% below that high. It still sits about 13% above its 200-day moving average. The Earnings Whispers trend readings are mixed, with sequential growth and momentum positive while AVWAP remains negative. That pattern fits a stock whose fundamentals keep improving even as holders have given back the October rally.

The bottom line is that GEO's quarter strengthened the earnings, balance-sheet, and contract-backlog story even as near-term revenue growth slows and fell short of expectations. Deleveraging, aggressive buybacks, and roughly $500 million of new annualized contract value give the company a credible path to reaccelerating in 2027. Execution on activations, the Adelanto repricing, and further asset sales will determine whether the market's recent skepticism was warranted.